Edition:
United States

GeneNews Ltd (GEN.TO)

GEN.TO on Toronto Stock Exchange

0.22CAD
26 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.22
Open
$0.22
Day's High
$0.22
Day's Low
$0.21
Volume
185,400
Avg. Vol
490,398
52-wk High
$0.57
52-wk Low
$0.14

GEN.TO

Chart for GEN.TO

About

GeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical... (more)
No analyst recommendations are available for GEN.TO.

Overall

Beta: --
Market Cap(Mil.): $19.29
Shares Outstanding(Mil.): 87.93
Dividend: --
Yield (%): --

Financials

  GEN.TO Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -0.10 -- --
ROI: -- -8.48 -5.42
ROE: -- -11.31 -4.68

BRIEF-Genenews Q1 loss per share $0.02

* Genenews announces q1-2017 financial results & provides progress update

May 11 2017

BRIEF-Genenews reports Q4 EPS $0.02

* Genenews announces fourth quarter and full year 2016 financial results

Apr 03 2017

BRIEF-Genenews Ltd says signed an agreement with a multi-specialty physician group in American Midwest

* Genenews Ltd says signed an agreement with a multi-specialty physician group in American Midwest for use of its cancer diagnostic tests Source text for Eikon: Further company coverage:

Mar 16 2017

BRIEF-Genenews announces settlement agreement with HDL Liquidating Trust

* Genenews announces settlement agreement with hdl liquidating trust

Mar 09 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.